『Update on Reproxalap PDUFA Timing』のカバーアート

Update on Reproxalap PDUFA Timing

Update on Reproxalap PDUFA Timing

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

Aldeyra provides an update on the timing of its dry eye disease treatment candidate reproxalap; Ocular Therapeutix pursues an accelerated NDA pathway for wet AMD therapy Axpaxli; and companies with late-stage drug candidates announce FDA submission plans. Learn more about your ad choices. Visit megaphone.fm/adchoices
まだレビューはありません